AKT1 and thyroid cancer: As a result of our increased understanding of the pathogenesis of thyroid cancer, aberrant activation of MEK/ERK and/or phosphatidylinositol-3 kinase (PI3K)/AKT pathways are known to play fundamental roles in thyroid cancer progression [6, 7].